The new ImpactAir-ISO-90 and ImpactAir-90 ranges are designed for use in high-grade areas within the pharmaceutical, healthcare, and specialist food industries where process monitoring of viable particles is necessary.
Cherwell introduced new models to its ImpactAir range of microbial air monitors distributed from Pinpoint Scientific.
The new ImpactAir-ISO-90 and ImpactAir-90 ranges are designed for use in high-grade areas within the pharmaceutical industry as well as other industries (e.g., healthcare, specialist food industries) where process monitoring of viable particles is necessary. Both ranges are equipped with a chamber for a 90-mm petri dish and use a slit-to-agar method that ensures particles, including microbes, impact the petri dish’s agar surface. As the dish rotates under the inlet, air is impacted onto an area of agar, reducing twin impingement risk and microbe desiccation for a high biological and physical efficiency.
Additionally, each range includes an ISO-90 Monitoring Head that contains all the controls needed to rotate the agar plate during the monitoring phase.
Individually, the ISO-90 range consists of:
The ImpactAir-90 range includes:
“We are really excited by the opportunities that the new range of air monitors from Pinpoint offer,” said Andy Whittard, managing director at Cherwell, in an April 21, 2021 press release. “The compact, 90-mm Petri version slit-to-agar range can help users address the challenges presented by the new Annex 1 and the focus on continuous monitoring. The various options also provide users with differing solutions for challenges within their facilities.”
Source: Cherwell
Clinical Supply Planning in Europe - Balancing Cost, Flexibility and Time
December 19th 2024The packaging and distribution of clinical supplies is a fundamental piece to the overall success of a clinical trial, and advance preparation can help establish a more efficient supply chain. Selecting the best geographical location for those activities, however, depends on the clinical trial protocol, business decisions, and even the investigational medicinal product (IMP) being studied.